Laboratorios Farmacéuticos Rovi SA logo

Laboratorios Farmacéuticos Rovi SA (ROVI)

Market Closed
16 Oct, 03:30 PM
XMAD XMAD
€
58. 15
+0.55
+0.9549%
€
4.63B Market Cap
- P/E Ratio
4.37% Div Yield
120,888 Volume
- Eps
€ 57.6
Previous Close
Add Transaction
Day Range
57.65 58.8
Year Range
53.1 86.7
Want to track ROVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Laboratorios Farmacéuticos Rovi SA (ROVI) Statistics

Valuation metrics

Market Cap 4.63B
Enterprise value 2.95B
Trailing P/E (ttm) 16.04
Forward P/E -
PEG ratio -2.39
Price/Sales (ttm) 3.84
Price/Book (mrq) 4.24
Enterprise Value/Revenue 3.82
Enterprise Value/EBITDA 11.08

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 94.33K
Average volume (90 days) 104.9K

Price summary

52-Week low 53.1
52-Week high 86.7
Beta -
50-Day moving average 58.93
200-Day moving average 63.22

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.78
Trailing annual dividend yield 0.0134%
5-Year annual dividend yield -
Payout ratio 0.26
Dividend Date 15 Jul 2026
Ex-Dividend Date 13 Jul 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.24%
Operating margin 0.22%

Operational effectiveness

Return on assets 0.16%
Return on equity 0.28%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 15.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.62
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 2.05%
Book value per share (mrq) 14.02

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -